Search

Your search keyword '"Doerk, T"' showing total 162 results

Search Constraints

Start Over You searched for: Author "Doerk, T" Remove constraint Author: "Doerk, T"
162 results on '"Doerk, T"'

Search Results

51. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

52. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

53. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

54. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

55. Abstract P5-10-09: Prospective cross-sectional-study on participation in mammography screening according to immigration background and education status

56. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

57. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

58. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

59. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1

60. Genetic predisposition to ductal carcinoma in situ of the breast

61. RAD51B in Familial Breast Cancer

62. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

63. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)

64. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

65. rs2735383, located at a microRNA binding site in the 3′UTR of NBS1, is not associated with breast cancer risk

66. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

67. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

68. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

69. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

70. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

71. Five endometrial cancer risk loci identified through genome-wide association analysis

72. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

73. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

74. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

75. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair

76. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

77. Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk

78. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

79. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

80. Genome-wide significant risk associations for mucinous ovarian carcinoma

81. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

82. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

83. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1

84. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

85. Comparison of 6q25 Breast Cancer Hits from Asian and\ud European Genome Wide Association Studies in the\ud Breast Cancer Association Consortium (BCAC)

86. Common variants at 19p13 are associated with susceptibility to ovarian cancer

88. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

89. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

90. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

91. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

92. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

93. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

94. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

95. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

96. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

97. Genome-wide association analysis identifies three new breast cancer susceptibility loci

98. Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

99. 11q13 is a susceptibility locus for hormone receptor positive breast cancer

100. 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

Catalog

Books, media, physical & digital resources